AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.39B
1-Year Est. Return 230.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+230.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$399M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
110
New
Increased
Reduced
Closed

Top Buys

1
+$54.2M
2
+$18.4M
3
+$15.9M
4
SLNO icon
Soleno Therapeutics
SLNO
+$14.8M
5
CYTK icon
Cytokinetics
CYTK
+$14.4M

Top Sells

1
+$32M
2
+$12.5M
3
+$8.84M
4
INZY
Inozyme Pharma
INZY
+$7M
5
VERA icon
Vera Therapeutics
VERA
+$5.59M

Sector Composition

1 Healthcare 91.07%
2 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTX icon
76
Context Therapeutics
CNTX
$215M
$390K 0.04%
402,653
-115,372
RPTX
77
DELISTED
Repare Therapeutics
RPTX
$352K 0.03%
200,000
CBIO
78
Crescent Biopharma
CBIO
$333M
$214K 0.02%
17,998
-262,033
ADGM
79
Adagio Medical Holdings
ADGM
$21M
$155K 0.01%
80,000
QTTB icon
80
Q32 Bio
QTTB
$61.6M
$55K 0.01%
27,777
SPRY icon
81
ARS Pharmaceuticals
SPRY
$892M
$25.1K ﹤0.01%
+2,500
RCKTW icon
82
Rocket Pharmaceuticals Warrant
RCKTW
$2.35M
$2.99K ﹤0.01%
75,000
ABUS icon
83
Arbutus Biopharma
ABUS
$873M
– –
0
ALT icon
84
Altimmune
ALT
$521M
– –
0
AMGN icon
85
Amgen
AMGN
$204B
– –
0
AXSM icon
86
Axsome Therapeutics
AXSM
$8.54B
– –
-50,000
BPMC
87
DELISTED
Blueprint Medicines
BPMC
– –
-250,000
CAPR icon
88
Capricor Therapeutics
CAPR
$1.41B
– –
0
CRSP icon
89
CRISPR Therapeutics
CRSP
$5.62B
– –
0
EXEL icon
90
Exelixis
EXEL
$10.6B
– –
0
GALT icon
91
Galectin Therapeutics
GALT
$186M
– –
0
IMTXW
92
DELISTED
Immatics N.V. Warrants
IMTXW
– –
-187,204
INMB icon
93
INmune Bio
INMB
$36.2M
– –
0
INZY
94
DELISTED
Inozyme Pharma
INZY
– –
-1,749,359
KPTI icon
95
Karyopharm Therapeutics
KPTI
$169M
– –
0
MIRM icon
96
Mirum Pharmaceuticals
MIRM
$5.44B
– –
-24,692
NKTX icon
97
Nkarta
NKTX
$183M
– –
-800,000
NTLA icon
98
Intellia Therapeutics
NTLA
$1.65B
– –
0
NVAX icon
99
Novavax
NVAX
$1.54B
– –
0
OMER icon
100
Omeros
OMER
$812M
– –
0
1 2 3
4
5